Tevogen Bio Holdings (TVGN) Assets (2021 - 2026)

Tevogen Bio Holdings has reported Assets for 6 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 20.81% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 20.81% YoY), and the FY2025 full-year result was $4.4 million, up 26.61% from the prior year.
• Assets for Q1 2026 stood at $4.9 million, up from $4.4 million in the prior quarter.
• The five-year high for Assets was $357.1 million in Q4 2022, with the low at $3.3 million in Q2 2024.
• Historically, Assets has averaged $90.5 million across 5 years, with a median of $4.9 million in 2026.
• Annual changes were most pronounced in 2023 — Assets slumped 98.46% — and 2025, when it rose 28.97%.
• Tevogen Bio Holdings' Assets stood at $357.1 million in 2022, then tumbled by 98.46% to $5.5 million in 2023, then plunged by 37.12% to $3.5 million in 2024, then advanced by 26.61% to $4.4 million in 2025, then climbed by 12.27% to $4.9 million in 2026.
• The last three Assets figures came in at $4.9 million (Q1 2026), $4.4 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.